← Evidence map

ReviewDiabetologia2019

Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

Nathalie Esser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31089754